“A”/“An” Means “One or More,” Said the Federal Circuit…Again
October 25, 2023, 2:16 PM
In ABS Global, Inc. v. Cytonome/ST, LLC, No. 2022-1761, 2023 WL 6885009 (Fed. Cir. Oct. 19, 2023), the Federal Circuit issued a precedential reminder that the use of “a” or “an” means “one or more” in an open-ended claim unless the claims, the specification, or the prosecution history necessitates a departure of this long-held general rule. See, e.g., KCJ Corp. v. Kinetic Concepts, Inc., 223 F.3d 1351, 1355 (Fed. Cir. 2000) (“This court has repeatedly emphasized that an indefinite article ‘a’ or ‘an’ in patent parlance carries the meaning of ‘one or more’ in open-ended claims containing the transitional phrase ‘comprising’”). This rule was articulated over thirty years ago, see N. Am. Vaccine Inc. v. Am. Cyanamid Co., 7 F.3d 1571, 1576 (Fed. Cir. 1993) (“‘a’ can mean one or more”), and reiterated twenty years ago in Scanner Techs. Corp. v. ICOS Vision Sys. Corp., 365 F.3d 1299, 1305-06 (Fed. Cir. 2004) (“the article ‘a’ or ‘an’…mean[s] one or more elements or steps, unless there is evidence of a clear intent to limit the claims”). The disputed claim term at issue in ABS was “a sample stream” directed to microfluidic devices. See ABS, 2023 WL 6885009, at *5 (“There is no sufficient basis for rejecting the plural-allowing meaning of ‘a sample stream’ here.”).

Even through the variations in claim construction principles over this time period, cf. Tex. Digital Sys., Inc. v. Telegenix, Inc., 308 F.3d 1193, 1203-04 (Fed. Cir. 2002) (“dictionaries…are objective resources that serve as reliable sources of information on the established meanings that would have been attributed to the terms of the claims”); Teva Pharms. v. Sandoz, Inc., 574 U.S. 318 (2015) (“in patent construction, subsidiary factfinding is sometimes necessary [and] appellate courts [are required] to review all such subsidiary factual findings under the ‘clearly erroneous’ standard”), the standard regarding the meaning and scope of “a”/“an” has remained steady. The ABS decision is this decade’s confirmation of that long-standing principle.
First, “at least in an open-ended ‘comprising’ claim,” like claim 1 of the ’439 patent, “use of ‘a’ or ‘an’ before a noun naming an object” requires that the phrase be construed to mean “‘one or more’ unless the context sufficiently indicates otherwise.” Lite-Netics, 60 F.4th at 1345; see Salazar, 64 F.4th at 1315; Convolve, Inc. v. Compaq Computer Corp., 812 F.3d 1313, 1321 (Fed. Cir. 2016); Baldwin, 512 F.3d at 1342–43. The court has called this the “general rule,” adding that an exception “only arises where the language of the claims themselves, the specification, or the prosecution history necessitate a departure from the rule.” Baldwin, 512 F.3d at 1343.

To subscribe to our publications, click here.
News & Insights
News & Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
What Happens in Vegas Stays in Vegas: Third Circuit Parts Ways with Ninth Circuit and Reinstates Atlantic City Algorithmic-Pricing Claim
Axinn Viewpoints
Antitrust
What Should Directors Be Asking? Antitrust in the Boardroom
Podcast
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
Byline Articles
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials
American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives
Webinar
Antitrust
What's the Skinny on SCOTUS' Skinny Label Decision?
Webinar
Intellectual Property
National Bar Association Corporate Counsel Leadership Summit
Speaking Engagement
Antitrust